FPAS
DERM icon

Focus Partners Advisor Solutions’s Journey Medical DERM Stock Holding History

Focus Partners Advisor Solutions’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,006
Closed -$179K – 1135
2025
Q3 		$179K Buy
20,006
+10,006
+100% +$72.6K ﹤0.01% 1079
2025
Q2 		$71.8K Buy
+10,000
New +$69.1K ﹤0.01% 1067
2022
Q4 		– Sell
-10,000
Closed -$25K – 363
2022
Q3 		$25K Buy
+10,000
New +$34.1K ﹤0.01% 401

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Focus Partners Advisor Solutions's DERM Position: Q4 2025 in Review

Focus Partners Advisor Solutions sold out of Journey Medical (DERM) in Q4 2025, closing a stake of 20,006 shares — an estimated $179K sold.

Focus Partners Advisor Solutions first reported a position in DERM in Q3 2022 and held it in 3 quarters. The position peaked at $179K in Q3 2025. 77 funds tracked by Wall St. Rank hold DERM as of Q4 2025.

  • Focus Partners Advisor Solutions reported no remaining Journey Medical position as of Q4 2025 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 20,006 Journey Medical shares in Q4 2025, an estimated $179K.
  • Focus Partners Advisor Solutions first reported a position in Journey Medical in Q3 2022 and held it in 3 quarters.
  • Focus Partners Advisor Solutions's Journey Medical position peaked at $179K in Q3 2025.
  • 77 funds tracked by Wall St. Rank held Journey Medical as of Q4 2025.

Based on Focus Partners Advisor Solutions's 13F filing for Q4 2025, filed 11 Feb 2026.